← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
226	Conestoga Capital Advisors Wayne, Pennsylvania	$71.1M	+$72.2M	2	1.03%	Increased
227	YCM Yiheng Capital Management San Francisco, California	$70M	+$57M	2	2.82%	Increased
228	Polar Capital Holdings London, United Kingdom	$69.7M	+$12M	4	0.3%	Increased
229	FLAM First Light Asset Management Edina, Minnesota	$69.6M	+$1.24M	4	4.17%	Increased
230	Ensign Peak Advisors Salt Lake City, Utah	$68.9M	-$13.8M	15	0.14%	Reduced
231	John W. Bristol & Co New York	$68M	-$514K	1	1.25%	Reduced
232	Public Employees Retirement Association of Colorado Denver, Colorado	$67.7M	-$31.2M	17	0.29%	Reduced
233	NIP Nicholas Investment Partners Rancho Santa Fe, California	$67.1M	+$5.83M	4	4.21%	Increased
234	GGHC Gilder Gagnon Howe & Co New York	$66.7M	-$21.7M	8	0.33%	Reduced
235	MAM MPM Asset Management Boston, Massachusetts	$66.5M	$0	1	12.36%	Maintained
236	OCA Octagon Capital Advisors New York	$66.2M	+$45.9M	5	13.7%	Increased
237	Alyeska Investment Group Chicago, Illinois	$65.7M	+$9.26M	10	0.76%	Increased
238	VanEck Associates New York	$65.4M	-$2.83M	4	0.15%	Reduced
239	LOAMS Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland	$65.2M	+$2.32M	4	3.31%	Increased
240	ACM American Capital Management New York	$64.9M	$0	1	1.82%	Maintained
241	Cubist Systematic Strategies Stamford, Connecticut	$64.4M	+$15.1M	45	0.73%	Increased
242	State of New Jersey Common Pension Fund D Trenton, New Jersey	$64M	+$3.08M	14	0.21%	Increased
243	Sessa Capital New York	$63.6M	+$31.3M	3	2.39%	Increased
244	Eventide Asset Management Boston, Massachusetts	$63.2M	-$60.2M	2	0.85%	Reduced
245	CM Crestline Management Fort Worth, Texas	$63.1M	+$72.8M	1	5.44%	New
246	VCM Valiant Capital Management San Francisco, California	$62.5M	+$13.3M	2	4.69%	Increased
247	Riverbridge Partners Minneapolis, Minnesota	$61.4M	+$3.56M	1	0.62%	Increased
248	OM Opaleye Management Boston, Massachusetts	$61.3M	-$16.7M	4	10.18%	Reduced
249	MVP Miller Value Partners Sarasota, Florida	$60.4M	+$1.09M	1	1.44%	Increased
250	PHS PFM Health Sciences San Francisco, California	$60.1M	-$2.31M	3	1.88%	Reduced